European Companies Search Engine
EU funding (€3,464,964): A fully integrated, animal-free, end-to-end modelling approach to oral drug product development Hor16 Sept 2020 EU Research and Innovation programme "Horizon"
Overview
Text
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "Astrazeneca AB - EU funding (€3,464,964): A fully integrated, animal-free, end-to-end modelling approach to oral drug product development"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
